GlaxoSmithKline plc (LON:GSK) insider Simon Dingemans purchased 8 shares of the firm’s stock in a transaction that occurred on Monday, February 11th. The stock was bought at an average price of GBX 1,554 ($20.31) per share, for a total transaction of £124.32 ($162.45).
Shares of LON:GSK opened at GBX 1,547 ($20.21) on Thursday. GlaxoSmithKline plc has a 12-month low of GBX 1,235.20 ($16.14) and a 12-month high of GBX 1,724.50 ($22.53).
The firm also recently announced a dividend, which will be paid on Thursday, April 11th. Shareholders of record on Thursday, February 21st will be given a dividend of GBX 23 ($0.30) per share. This represents a dividend yield of 1.49%. The ex-dividend date is Thursday, February 21st. This is a positive change from GlaxoSmithKline’s previous dividend of $19.00.
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, and HIV, as well as vaccines.
Further Reading: What do investors mean by earnings per share?
Receive News & Ratings for GlaxoSmithKline Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline and related companies with MarketBeat.com's FREE daily email newsletter.